Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
<p><strong>Background:</strong> Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.</p> <p><strong>Methods:&l...
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Další autoři: | |
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Elsevier
2021
|